Reactive perforating collagenosis (RPC) is a cutaneous disorder that has rarely been associated with haematological malignancies. We present the case of a 47-year-old man with a 6-month history of Epstein–Barr virus-positive angioimmunoblastic T-cell lymphoma (AITL) who was undergoing chemotherapy and had an extremely pruritic, papular eruption that had worsened over the past 7 months. Skin biopsy findings revealed RPC. He was treated with triamcinolone cream and hydroxyzine alongside his chemotherapy; this resolved his symptoms. This patient’s case offers a unique clinicopathological presentation of RPC in the setting of AITL in the skin and demonstrates the importance of a dermatologist's management of cutaneous disorders in patients with cancer to improve their quality of life.
No takes yet. Share an insight, caveat, or question.
Chacko et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: